UL CELL
UL CELL
∞HUMAN REPAIR SYSTEMS™
∞HUMAN REPAIR SYSTEMS™
Autologous, gene-free induction of patient-derived MSCs into progenitor cell classes across six systems — RUO.
Autologous, gene-free induction of patient-derived MSCs into progenitor cell classes across six systems — RUO.
Autologous, gene-free induction of patient-derived MSCs into progenitor cell classes across six systems — RUO.
Backed by global experts in hematology, oncology and AI bioinformatics.
Backed by global experts in hematology, oncology and AI bioinformatics.
The Autologous Company™
The Autologous Company™
Human in vitro ✓ • Animal efficacy ✓ • Preclinical ✓ • RUO (Exo-X) ✓
Human in vitro ✓ • Animal efficacy ✓ • Preclinical ✓ • RUO (Exo-X) ✓
Products
∞KITS™ — Discovery & Research
Discovery kits for induction, QC and supportive reagents (RUO).
Discovery biology & platform/automation teams.
Assay dev cores & method transfer.
Organoid / disease model builders
∞KITS™ — Discovery & Research
Discovery kits for induction, QC and supportive reagents (RUO).
Discovery biology & platform/automation teams.
Assay dev cores & method transfer.
Organoid / disease model builders
∞KITS™ — Discovery & Research
Discovery kits for induction, QC and supportive reagents (RUO).
Discovery biology & platform/automation teams.
Assay dev cores & method transfer.
Organoid / disease model builders
∞RCaaS™ — Institutional Partners
Outcome-focused delivery of Assay-Qualified Cells with provenance and assay guidance (Institutional, RUO).
Pharmaceutical companies & translational consortia.
Contract research organizations (CROs).
Institutions scaling autologous workflows.
∞RCaaS™ — Institutional Partners
Outcome-focused delivery of Assay-Qualified Cells with provenance and assay guidance (Institutional, RUO).
Pharmaceutical companies & translational consortia.
Contract research organizations (CROs).
Institutions scaling autologous workflows.
∞RCaaS™ — Institutional Partners
Outcome-focused delivery of Assay-Qualified Cells with provenance and assay guidance (Institutional, RUO).
Pharmaceutical companies & translational consortia.
Contract research organizations (CROs).
Institutions scaling autologous workflows.
∞Private Access™ — Bespoke Programs
Invite-only access for private clients & family offices. Recovery / Maintenance / Longevity tracks with biobanking & longitudinal reporting.
Private clients & family offices.
Longevity & maintenance programs.
Biobanking with longitudinal dashboards.
∞Private Access™ — Bespoke Programs
Invite-only access for private clients & family offices. Recovery / Maintenance / Longevity tracks with biobanking & longitudinal reporting.
Private clients & family offices.
Longevity & maintenance programs.
Biobanking with longitudinal dashboards.
∞Private Access™ — Bespoke Programs
Invite-only access for private clients & family offices. Recovery / Maintenance / Longevity tracks with biobanking & longitudinal reporting.
Private clients & family offices.
Longevity & maintenance programs.
Biobanking with longitudinal dashboards.
Use Cases
Organoid platforms
Build patient-derived 3D models with functional organoid support.
Organoid platforms
Build patient-derived 3D models with functional organoid support.
Organoid platforms
Build patient-derived 3D models with functional organoid support.
CAR-T support
Develop non-integrating CAR-T/NK platforms for immune oncology.
CAR-T support
Develop non-integrating CAR-T/NK platforms for immune oncology.
CAR-T support
Develop non-integrating CAR-T/NK platforms for immune oncology.
COPD barrier models
Create reproducible barrier models with pulmonary progenitors.
COPD barrier models
Create reproducible barrier models with pulmonary progenitors.
COPD barrier models
Create reproducible barrier models with pulmonary progenitors.
Diabetes GSIS
Model glucose-stimulated insulin secretion with islet-like cells.
Diabetes GSIS
Model glucose-stimulated insulin secretion with islet-like cells.
Diabetes GSIS
Model glucose-stimulated insulin secretion with islet-like cells.
Systems Portfolio
Regenerative Cell-as-a-Service™ (RCaaS™)
Platform
RCaaS™ is the operating system that turns autologous MSCs into reproducible, assay-qualified repair progenitors — with provenance, QC gates, and white-glove onboarding.
Discovery Kits
Induction
AI-QC SaaS
QC Panels
Node Labs
Execution
AQC Release
Phenotype + Function
Ready Cells
By System
All Ready Cells below are delivered under the RCaaS™ framework (RUO) with a Digital Batch Passport™ and acceptance thresholds.
∞HEMO™
RCaaS-Delivered
RUO
Assay-Qualified CD34⁺ Hematopoietic Progenitors (RUO)
Identity
Enriched CD34⁺ population; includes CD34⁺CD38⁻CD90⁺ subsets.
Functionality
CFU-competent; multi-lineage differentiation into erythroid, myeloid, and lymphoid cells.
Applications
Hematopoietic disease modeling
Immune reconstitution research
Drug screening
QC Layer
Released only under agreed phenotype/functional panels with Digital Batch Passport™.
∞HEMO™
RCaaS-Delivered
RUO
Assay-Qualified CD34⁺ Hematopoietic Progenitors (RUO)
Identity
Enriched CD34⁺ population; includes CD34⁺CD38⁻CD90⁺ subsets.
Functionality
CFU-competent; multi-lineage differentiation into erythroid, myeloid, and lymphoid cells.
Applications
Hematopoietic disease modeling
Immune reconstitution research
Drug screening
QC Layer
Released only under agreed phenotype/functional panels with Digital Batch Passport™.
∞HEMO™
RCaaS-Delivered
RUO
Assay-Qualified CD34⁺ Hematopoietic Progenitors (RUO)
Identity
Enriched CD34⁺ population; includes CD34⁺CD38⁻CD90⁺ subsets.
Functionality
CFU-competent; multi-lineage differentiation into erythroid, myeloid, and lymphoid cells.
Applications
Hematopoietic disease modeling
Immune reconstitution research
Drug screening
QC Layer
Released only under agreed phenotype/functional panels with Digital Batch Passport™.
∞PULMA™
RCaaS-Delivered
RUO
Assay-Qualified Pulmonary Progenitors (RUO)
Identity
EpCAM⁺ airway + alveolar progenitors.
Functionality
Barrier-forming compatible
Airway multi-lineage differentiation
Applications
Respiratory disease models (COPD, ARDS, fibrosis)
Lung toxicity assays
QC Layer
Provenance summary + assay thresholds; RCaaS-deployable.
∞PULMA™
RCaaS-Delivered
RUO
Assay-Qualified Pulmonary Progenitors (RUO)
Identity
EpCAM⁺ airway + alveolar progenitors.
Functionality
Barrier-forming compatible
Airway multi-lineage differentiation
Applications
Respiratory disease models (COPD, ARDS, fibrosis)
Lung toxicity assays
QC Layer
Provenance summary + assay thresholds; RCaaS-deployable.
∞PULMA™
RCaaS-Delivered
RUO
Assay-Qualified Pulmonary Progenitors (RUO)
Identity
EpCAM⁺ airway + alveolar progenitors.
Functionality
Barrier-forming compatible
Airway multi-lineage differentiation
Applications
Respiratory disease models (COPD, ARDS, fibrosis)
Lung toxicity assays
QC Layer
Provenance summary + assay thresholds; RCaaS-deployable.
∞GLYCO™
RCaaS-Delivered
RUO
Islet-like β-Cell Induced Cells (RUO)
Identity
β-like cells with metabolic lineage markers; α/β/δ compatibility.
Functionality
GSIS-positive (glucose-stimulated insulin secretion); metabolic response validated.
Applications
Diabetes disease modeling
Drug efficacy screening
Islet organoid co-culture
QC Layer
Function-Matched Lot™ selection; Digital Batch Passport™ with provenance records.
∞GLYCO™
RCaaS-Delivered
RUO
Islet-like β-Cell Induced Cells (RUO)
Identity
β-like cells with metabolic lineage markers; α/β/δ compatibility.
Functionality
GSIS-positive (glucose-stimulated insulin secretion); metabolic response validated.
Applications
Diabetes disease modeling
Drug efficacy screening
Islet organoid co-culture
QC Layer
Function-Matched Lot™ selection; Digital Batch Passport™ with provenance records.
∞GLYCO™
RCaaS-Delivered
RUO
Islet-like β-Cell Induced Cells (RUO)
Identity
β-like cells with metabolic lineage markers; α/β/δ compatibility.
Functionality
GSIS-positive (glucose-stimulated insulin secretion); metabolic response validated.
Applications
Diabetes disease modeling
Drug efficacy screening
Islet organoid co-culture
QC Layer
Function-Matched Lot™ selection; Digital Batch Passport™ with provenance records.
∞NEURA™
RCaaS-Delivered
RUO
Neural Progenitors (RUO)
Identity
Nestin⁺ / TUJ1⁺ progenitors; astrocytic and dopaminergic lineage potential.
Functionality
Neurite outgrowth positive
Electrophysiology / synaptic marker expression
Applications
Neurodegeneration & aging models
Brain organoids
CNS drug/tox screening
QC Layer
Organoid-ready; provenance & release data included; RCaaS-compatible.
∞NEURA™
RCaaS-Delivered
RUO
Neural Progenitors (RUO)
Identity
Nestin⁺ / TUJ1⁺ progenitors; astrocytic and dopaminergic lineage potential.
Functionality
Neurite outgrowth positive
Electrophysiology / synaptic marker expression
Applications
Neurodegeneration & aging models
Brain organoids
CNS drug/tox screening
QC Layer
Organoid-ready; provenance & release data included; RCaaS-compatible.
∞NEURA™
RCaaS-Delivered
RUO
Neural Progenitors (RUO)
Identity
Nestin⁺ / TUJ1⁺ progenitors; astrocytic and dopaminergic lineage potential.
Functionality
Neurite outgrowth positive
Electrophysiology / synaptic marker expression
Applications
Neurodegeneration & aging models
Brain organoids
CNS drug/tox screening
QC Layer
Organoid-ready; provenance & release data included; RCaaS-compatible.
∞CARDIA™
RCaaS-Delivered
RUO
Cardiomyocyte Progenitors (RUO)
Identity
Contractility and electrophysiology validated
Vascular co-differentiation capacity
Functionality
GSIS-positive (glucose-stimulated insulin secretion); metabolic response validated.
Applications
Cardiovascular disease modeling
Cardiotoxicity assays
Myocardial repair research
QC Layer
Identity- and function-gated; cryo-ready with reproducible thaw performance.
∞CARDIA™
RCaaS-Delivered
RUO
Cardiomyocyte Progenitors (RUO)
Identity
Contractility and electrophysiology validated
Vascular co-differentiation capacity
Functionality
GSIS-positive (glucose-stimulated insulin secretion); metabolic response validated.
Applications
Cardiovascular disease modeling
Cardiotoxicity assays
Myocardial repair research
QC Layer
Identity- and function-gated; cryo-ready with reproducible thaw performance.
∞CARDIA™
RCaaS-Delivered
RUO
Cardiomyocyte Progenitors (RUO)
Identity
Contractility and electrophysiology validated
Vascular co-differentiation capacity
Functionality
GSIS-positive (glucose-stimulated insulin secretion); metabolic response validated.
Applications
Cardiovascular disease modeling
Cardiotoxicity assays
Myocardial repair research
QC Layer
Identity- and function-gated; cryo-ready with reproducible thaw performance.
∞IMMUNE™
RCaaS-Delivered
RUO
Autologous Immune Progenitors (RUO)
Identity
T/B/NK lineage precursors; HSPC-compatible induction.
Functionality
CAR-supportive (non-genetic)
Cytokine response and proliferation assays
Applications
Immunology modeling
CAR-T / CAR-NK support
Immune reconstruction studies
QC Layer
Autologous-only lot release; Digital Batch Passport™; RCaaS-deployable.
∞IMMUNE™
RCaaS-Delivered
RUO
Autologous Immune Progenitors (RUO)
Identity
T/B/NK lineage precursors; HSPC-compatible induction.
Functionality
CAR-supportive (non-genetic)
Cytokine response and proliferation assays
Applications
Immunology modeling
CAR-T / CAR-NK support
Immune reconstruction studies
QC Layer
Autologous-only lot release; Digital Batch Passport™; RCaaS-deployable.
∞IMMUNE™
RCaaS-Delivered
RUO
Autologous Immune Progenitors (RUO)
Identity
T/B/NK lineage precursors; HSPC-compatible induction.
Functionality
CAR-supportive (non-genetic)
Cytokine response and proliferation assays
Applications
Immunology modeling
CAR-T / CAR-NK support
Immune reconstruction studies
QC Layer
Autologous-only lot release; Digital Batch Passport™; RCaaS-deployable.
∞EXO-X™
RCaaS-Delivered
RUO
Assay-qualified autologous exosome fractions for research (RUO).
Identity
NTA size distribution (typ. 50–150 nm); particle/event reporting
Markers: CD63/CD81/CD9; negatives documented (e.g., Calnexin)
Functionality
Uptake & paracrine signaling research
Compatibility with organoid/co-culture assays (RUO)
Applications
Cell-free regenerative mechanism studies
Disease modeling & method development (research only)
QC Layer
Provenance summary + suggested marker/particle thresholds
Digital Batch Passport™ (RUO)
∞EXO-X™
RCaaS-Delivered
RUO
Assay-qualified autologous exosome fractions for research (RUO).
Identity
NTA size distribution (typ. 50–150 nm); particle/event reporting
Markers: CD63/CD81/CD9; negatives documented (e.g., Calnexin)
Functionality
Uptake & paracrine signaling research
Compatibility with organoid/co-culture assays (RUO)
Applications
Cell-free regenerative mechanism studies
Disease modeling & method development (research only)
QC Layer
Provenance summary + suggested marker/particle thresholds
Digital Batch Passport™ (RUO)
∞EXO-X™
RCaaS-Delivered
RUO
Assay-qualified autologous exosome fractions for research (RUO).
Identity
NTA size distribution (typ. 50–150 nm); particle/event reporting
Markers: CD63/CD81/CD9; negatives documented (e.g., Calnexin)
Functionality
Uptake & paracrine signaling research
Compatibility with organoid/co-culture assays (RUO)
Applications
Cell-free regenerative mechanism studies
Disease modeling & method development (research only)
QC Layer
Provenance summary + suggested marker/particle thresholds
Digital Batch Passport™ (RUO)
Scientific Authority
Scientific Authority
First-in-class† • Favorable WIPO ISR/WO
Data Packages
Assay panels, QC specs and overview packs available upon request (RUO).
Global Footprint
Singapore • Shanghai • Kyoto • Atlanta